While the diabetes drug Ozempic has taken the weight loss world by storm, there is another option that may prove even more effective.
Isabel Cameron is a reporter for BioPharma-Reporter and Outsourcing-Pharma. With a focus on the pharmaceutical industry, her articles cover a wide range of topics including drug approvals, industry trends, manufacturing developments, and clinical trials. She provides in-depth analysis and reporting on the latest advancements and news within the biopharmaceutical sector.